Literature DB >> 266416

Timed sequential therapy of human leukemia based upon the response of leukemic cells to humoral growth factors.

P J Burke, J E Karp, H G Braine, W P Vaughan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 266416

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  13 in total

Review 1.  The role of timed sequential chemotherapy in adult acute myelogenous leukemia.

Authors:  Xavier Thomas
Journal:  Curr Hematol Malig Rep       Date:  2008-04       Impact factor: 3.952

2.  Pretreatment of cytokinetics in acute myelogenous leukemia. Age-related prognostic implications.

Authors:  H M Kantarjian; B Barlogie; M J Keating; R R Hall; T L Smith; K B McCredie; E J Freireich
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

3.  Intensification of remission induction therapy for acute nonlymphocytic leukemia (ANLL). I. Response and toxicity in four different regimens.

Authors:  T Büchner; D Urbanitz; W Hiddemann; D Kamanabroo; R Meister; L Balleisen; U Delvos; E M Lagrèze; U Schmitz-Huebner; H Schulte; J van de Loo
Journal:  Blut       Date:  1979-08

4.  The relevance of cell kinetics for optimal scheduling of 1-beta-D-arabinofuranosyl cytosine and methotrexate in a slow growing acute myeloid leukemia (BNML).

Authors:  M Aglietta; P Sonneveld
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 5.  Bench to bedside targeting of FLT3 in acute leukemia.

Authors:  Keith W Pratz; Mark J Levis
Journal:  Curr Drug Targets       Date:  2010-07       Impact factor: 3.465

6.  Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia.

Authors:  Joshua F Zeidner; Matthew C Foster; Amanda L Blackford; Mark R Litzow; Lawrence E Morris; Stephen A Strickland; Jeffrey E Lancet; Prithviraj Bose; M Yair Levy; Raoul Tibes; Ivana Gojo; Christopher D Gocke; Gary L Rosner; Richard F Little; John J Wright; L Austin Doyle; B Douglas Smith; Judith E Karp
Journal:  Haematologica       Date:  2015-05-28       Impact factor: 9.941

7.  Timed sequential therapy of the selective T-type calcium channel blocker mibefradil and temozolomide in patients with recurrent high-grade gliomas.

Authors:  Matthias Holdhoff; Xiaobu Ye; Jeffrey G Supko; Louis B Nabors; Arati S Desai; Tobias Walbert; Glenn J Lesser; William L Read; Frank S Lieberman; Martin A Lodge; Jeffrey Leal; Joy D Fisher; Serena Desideri; Stuart A Grossman; Richard L Wahl; David Schiff
Journal:  Neuro Oncol       Date:  2017-06-01       Impact factor: 12.300

8.  Intensively timed combination chemotherapy for the induction of adult patients with acute myeloid leukemia: long-term follow-up of a phase 2 study.

Authors:  Michael Rytting; Farhad Ravandi; Elihu Estey; Jorge Cortes; Stefan Faderl; Guillermo Garcia-Manero; Sima Jeha; Souzanne Ouzounian; Sherry Pierce; Hagop Kantarjian
Journal:  Cancer       Date:  2010-11-15       Impact factor: 6.860

Review 9.  Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature.

Authors:  Kelly J Norsworthy; Amy E DeZern; Hua-Ling Tsai; Wesley A Hand; Ravi Varadhan; Steven D Gore; Ivana Gojo; Keith Pratz; Hetty E Carraway; Margaret Showel; Michael A McDevitt; Douglas Gladstone; Gabriel Ghiaur; Gabrielle Prince; Amy H Seung; Dina Benani; Mark J Levis; Judith E Karp; B Douglas Smith
Journal:  Leuk Res       Date:  2017-08-30       Impact factor: 3.156

10.  Increased incidence of fungemia caused by Candida krusei.

Authors:  W G Merz; J E Karp; D Schron; R Saral
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.